The USA’s Food and Drug Administration and informed consent

By Hugh Davies The Food and Drug Administration’s (FDA) initiative Over the last three decades seeking consent of patients or volunteers to join a medical research study has become dominated by an increasingly lengthy, opaque and Participant Information Sheet (PIS), shielding the researcher from liability. The FDA argues that Informed consent documents are often long, […]

Read More…

Simulated empathy in surgical informed consent: Should AI comfort patients or just inform them?

By Pranab Rudra. The use of AI in healthcare is rapidly expanding, raising critical ethical questions about its role in informed consent, a process that relies not only on clear, accurate information but also on genuine human connection. This focus is crucial because informed consent is both an informational and an emotional interaction, and any […]

Read More…

The doctor will speak as you prefer? How AI could personalize medical communication

By Hazem Zohny, Jemima Winfried Allen, Dominic Wilkinson, and Julian Savulescu. When you go to the doctor, there’s little telling what kind of communicator you’ll get. Some doctors are on the paternalistic side, telling you what you should do without much discussion. Others just give you the facts and leave the decision entirely to you. […]

Read More…

Exploring the ethical controversy of ‘live tissue training’

By Cara Swain ‘Live tissue training’ (or LTT) is a term used to describe the use of living anaesthetised animals for medical education purposes. Within surgical specialties, live animals are used for skill acquisition and practice in a variety of surgical techniques, including laparoscopic, endoscopic, robotic, microsurgery as well as traditional ‘open’ surgery. Examples range […]

Read More…

Beyond ‘do no harm’: The ethics of maximizing benefit from psychedelics in healthcare

By Jason Luoma and Brian Pilecki. The use of psychedelics in the USA has rapidly increased over the last decade, not only for recreational purposes but also for therapeutic purposes. For example, rates of Google searches on microdosing have skyrocketed since 2015 demonstrating strong interest in using psychedelics for improving personal well-being among the public. […]

Read More…

Confucian-inspired global bioethics

By Nancy S. Jecker and Roger Yat-Nork Chung. Bioethics faces challenges with respect to equity, diversity, and inclusion. As a group, we bioethicists are unrepresentative of the global population we increasingly serve. Leading bioethics scholars and institutions are situated mostly in the politically and economically dominant countries of the Global North. Within countries, bioethicists are […]

Read More…

Jannik Sinner: The world’s best male tennis player has been banned for doping – but the real sinner is not Jannik, it’s WADA

By Thomas Søbirk Petersen. The tennis world is in shock. Jannik Sinner, the men’s Number 1-ranked tennis player and winner of the two recent grand slams in tennis (the US Open 2024 and the Australian Open 2025), has received a three-month doping ban from the World Anti-Doping Agency (WADA). The ban was initiated on February […]

Read More…

Redefining non-maleficence: what is the role of harm in end-of-life choices?

By David Geddes. Since Beauchamp and Childress introduced the four pillars of medical ethics in their 1979 book Principles on Biomedical Ethics, there has been a discourse on which of the pillars, if any, accurately upholds the principles and values of contemporary medicine. Each pillar can be considered fundamental in some contexts, yet in others […]

Read More…

Should virtual assistants be used to help people in vulnerable positions access care?

By Steven R. Kraaijeveld, Hanneke van Heijster, Nadine Bol, and Kris E. Bevelander. The rising costs of health care in Europe and many countries around the world have led to calls to use technology and digitalization to “drive more equitable and sustainable outcome for all”.  Digitalizing parts of health care may not only reduce costs, […]

Read More…